Reporting owner · Q3 2026 · CIK 1543663

Cvijic Christine Mikail: insider trades.

Cvijic Christine Mikail reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($340K), across 1 company.

Transactions
5
Purchases (P)
0
Sales (S)
5
Companies
1
Name as filed
Cvijic Christine Mikail

Companies

CompanyRelationshipTransactions
Neurogene Inc. (NGNE)Director, Officer · President and CFO5

Transactions

5 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-07-07Neurogene Inc.S4,200$36.1384,040Form 4
2026-07-06Neurogene Inc.S600$36.0288,240Form 4
2026-07-02Neurogene Inc.S2,531$34.5890,370Form 4
2026-07-02Neurogene Inc.S1,530$35.2388,840Form 4
2026-07-01Neurogene Inc.S739$34.0692,901Form 4

Questions

What stock did Cvijic Christine Mikail buy or sell?

Cvijic Christine Mikail reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($340K), across 1 company.

Is Cvijic Christine Mikail the same person as other filers with this name?

This page covers SEC CIK 1543663 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/cvijic-christine-mikail-1543663.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.